Jubilant Generics Limited, a active public limited foreign company incorporated in india, was established on 25 November 2013 in Noida, Uttar Pradesh, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24100UP2013FLC060821. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.58 Cr.
It upholds a compliant status. Employing 1,106 professional, Its leadership includes Gayatri Taragi (Director), Jaidev Sanjeev Rajpal (Ceo), Shirish Gundopant Belapure (Director). Past directors included Gurpartap Singh Sachdeva, Arvind Chokhany, Shyam Sunder Bhartia. It holds ₹500.00 Cr open charges and ₹810.00 Cr settled loans. Its latest AGM occurred on 28 August 2025, with the balance sheet filed on 31 March 2025. It is based at Plot 1A, Sector 16A, Institutional Area, Noida, Noida, Uttar Pradesh, 201301.
U24100UP2013FLC060821
060821
25 November 2013
₹3.00 Cr
₹2.58 Cr
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Jubilant Generics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gayatri Taragi | Director | 21 May 2024 | Current |
| Jaidev Sanjeev Rajpal | Ceo | 11 Oct 2022 | Current |
| Shirish Gundopant Belapure | Director | 20 Jun 2024 | Current |
| Jasdeepsingh Gurdeepsingh Sood | Whole-Time Director | 14 May 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Mar 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2021 | Past |
| Pramod Abcsdd | Director | 25 Sep 2015 | Past |
| Pramod Abcsdd | Director | 10 Oct 2016 | Past |
| Pramod Abcsdd | Additional Director | 22 Aug 2016 | Past |
| Pramod Abcsdd | Director | 01 Apr 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jubilant Generics Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 74.67% decrease. The company also saw a substantial fall in profitability, with a 1618.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 53.06%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Jubilant Generics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000,000.00
₹8,100,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jan 2015 | Others | ₹500.00 Cr | Open |
| 05 Feb 2016 | Indusind Bank Ltd. | ₹100.00 Cr | Satisfied |
| 30 Sep 2014 | Il & Fs Trust Company Limited | ₹130.00 Cr | Satisfied |
| 23 Sep 2014 | Export Import Bank Of India | ₹30.00 Cr | Satisfied |
| 30 Jul 2014 | The Ratnakar Bank Limited | ₹50.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Jubilant Generics has a workforce of 1106 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Jubilant Generics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jubilant Generics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Jubilant Generics Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records. was recorded as a recent event.
Progress on Jubilant Generics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was documented.
The activity Shikha Aggarwal was appointed as a Cfo was appointed as a Cfo on 01 Aug 2024 & has been associated with this company since 1 year 3 months . was completed.
Shirish Gundopant Belapure was appointed as a Director was appointed as a Director on 20 Jun 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.
The activity Gayatri Taragi was appointed as a Director was appointed as a Director on 21 May 2024 & has been associated with this company since 1 year 6 months . was completed.
Progress on Jaidev Sanjeev Rajpal was appointed as a CEO was appointed as a CEO on 11 Oct 2022 & has been associated with this company since 3 years 1 month . was documented.
The CIN of Jubilant Generics Limited is U24100UP2013FLC060821.
Jubilant Generics Limited is headquartered at Plot 1A, Sector 16A, Institutional Area, Noida, Noida, Uttar Pradesh, 201301.
Jubilant Generics Limited was incorporated on 25 November 2013.
The current directors of Jubilant Generics Limited are
The primary industry of Jubilant Generics Limited is Manufacturing.
Jubilant Generics Limited is unlisted.
The authorized capital of Jubilant Generics Limited is ₹3.00 Cr, and the paid-up capital is ₹2.58 Cr.
The compliance status of Jubilant Generics Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX